GLAPFGlanbia plc
The schedule
- Thu15Oct
Management overview of strategic initiatives, capital allocation, and long-term brand targets.
- Wed24Feb
Full-year fiscal performance and forward guidance for 2027.
- Mon10May
Industry-wide review of dairy commodity pricing and its impact on whey protein input costs.
Past
- Thu6Aug
Actual outcome: Bull · $27.85 at outcome
Glanbia announced a full-year profit forecast hike driven by explosive demand for protein products, particularly from weight-loss drug users. This directly boosted margins and long-term growth prospects for protein-based nutrition supplements. [Market retrospective · Long-Term (31–75 days)] Missed anticipation: +45.9% from 2026-03-20 to 2026-08-14 (~2.9σ vs typical 75d vol). Target evaluation date 2026-09-06 (not yet reached as of 2026-08-14). Confidence 95%.
Glanbia announced a full-year profit forecast hike driven by explosive demand for protein products, particularly from weight-loss drug users. This directly boosted margins and long-term growth prospects for protein-based nutrition supplements. [Market retrospective · Long-Term (31–75 days)] Missed anticipation: +45.9% from 2026-03-20 to 2026-08-14 (~2.9σ vs typical 75d vol). Target evaluation date 2026-09-06 (not yet reached as of 2026-08-14). Confidence 95%.